Clinical Trial Update: Comparison of Response Between Combination of Transarterial Chemoembolization and Lenvatinib Therapy Versus Lenvatinib Monotherapy in Patients With Unresectable Hepatocellular Carcinoma [NA]

View source ↗

Summary

Clinical trial comparing combination therapy of transarterial chemoembolization plus lenvatinib versus lenvatinib alone in unresectable hepatocellular carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• LENVIMA (lenvatinib)

Snippet

Sponsor: Bangladesh Medical University | Conditions: Unresectable Hepatocellular Carcinoma (HCC) | NA | Status: RECRUITING